Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04301934 · ClinicalTrials.gov registry record · NA
Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04301934: Completed NA study, sponsored by Mayo Clinic.
NCT04301934 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04301934, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Randomized controlled trial to determine clinical and microbiome difference between fractional CO2 Laser and vaginal estrogen in treating patients with recurrent urinary tract infection (UTI).
Primary Outcome
Prevalence of urinary tract infections (UTI) described as percentage of subjects with none vs one or more UTI.
Interventions
- DRUG Estradiol
- DEVICE Mona Lisa Touch
- DRUG Conjugated estrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT04301934 record still lists
NCT04301934 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Estradiol is the first listed.
NCT04301934 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04301934 about?
NCT04301934 is a clinical study titled "Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection". Randomized controlled trial to determine clinical and microbiome difference between fractional CO2 Laser and vaginal estrogen in treating patients with recurrent urinary tract infection (UTI).
What is the current status of trial NCT04301934?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-06-01. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT04301934?
The interventions under investigation include: Estradiol (DRUG), Mona Lisa Touch (DEVICE), Conjugated estrogen (DRUG).
Who is sponsoring clinical trial NCT04301934?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04301934's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI